Literature DB >> 8382392

RNA-stimulated NTPase activity associated with the p80 protein of the pestivirus bovine viral diarrhea virus.

J K Tamura1, P Warrener, M S Collett.   

Abstract

The genomic RNA of pestiviruses contains a single large open frame coding for virion structural proteins and viral nonstructural polypeptides. Based on the presence of specific amino acid sequence motifs, pestivirus nonstructural protein p80 was predicted to be both a serine-type proteinase and a nucleoside triphosphatase (NTPase)/RNA helicase. We previously demonstrated p80 possesses the former activity (Wisherchen and Collett, Virology 184, 341-350, 1991). Here, we provide experimental evidence that this protein is also an RNA-stimulated NTPase. Employing immunoaffinity chromatography, we partially purified a p80 protein analog (p87) from recombinant baculovirus-infected insect cells. We show this preparation contained a specific NTPase activity. This activity was not found in material similarly purified from lysates of baculovirus-infected insect cells not expressing the p87 protein. That the NTPase activity was associated with the p87 polypeptide was demonstrated in two ways. First, the NTPase activity was shown to be completely inhibited by monoclonal antibodies specific to the p80 polypeptide, but was unaffected by monoclonal antibodies to unrelated antigens. Second, radiolabeled ATP could be specially cross-linked to the p87 polypeptide. NTP hydrolysis by the p87 protein was stimulated by the presence of particular single-strand RNA molecules. Initial enzymologic characterization of the pestivirus p80 NTPase is presented, and the presumptive role of this activity in pestivirus replication is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382392     DOI: 10.1006/viro.1993.1097

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  47 in total

1.  Mutations in the 5' nontranslated region of bovine viral diarrhea virus result in altered growth characteristics.

Authors:  P Becher; M Orlich; H J Thiel
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication.

Authors:  A E Matusan; M J Pryor; A D Davidson; P J Wright
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Persistence of bovine viral diarrhea virus is determined by a cellular cofactor of a viral autoprotease.

Authors:  T Lackner; A Müller; M König; H-J Thiel; N Tautz
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 4.  Molecular targets for flavivirus drug discovery.

Authors:  Aruna Sampath; R Padmanabhan
Journal:  Antiviral Res       Date:  2008-09-15       Impact factor: 5.970

5.  RNA helicase activity of the plum pox potyvirus CI protein expressed in Escherichia coli. Mapping of an RNA binding domain.

Authors:  A Fernández; S Laín; J A García
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

6.  Characterization of an ATPase activity in reovirus cores and its genetic association with core-shell protein lambda1.

Authors:  S Noble; M L Nibert
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  ATPase, GTPase, and RNA binding activities associated with the 206-kilodalton protein of turnip yellow mosaic virus.

Authors:  G Kadaré; C David; A L Haenni
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  Serine protease of pestiviruses: determination of cleavage sites.

Authors:  N Tautz; K Elbers; D Stoll; G Meyers; H J Thiel
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

Review 9.  Virus-encoded RNA helicases.

Authors:  G Kadaré; A L Haenni
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

10.  A single point mutation in nonstructural protein NS2 of bovine viral diarrhea virus results in temperature-sensitive attenuation of viral cytopathogenicity.

Authors:  Alexander Pankraz; Simone Preis; Heinz-Jürgen Thiel; Andreas Gallei; Paul Becher
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.